Form 4: Guardant Health Executive Receives Stock Options and Restricted Stock Units

Terilyn J. Monroe, Chief People Officer at Guardant Health, was granted stock options and restricted stock units on November 8, 2024.

Summary

• Terilyn J. Monroe, the Chief People Officer of Guardant Health, received a grant of 47,627 stock options with an exercise price of $28.61 on November 8, 2024.
• These stock options vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting in equal monthly installments over the following two years.
• Monroe also received 31,751 restricted stock units (RSUs) on the same date.
• These RSUs also vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting in equal quarterly installments over the following two years.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management with shareholder interests. There are no negative implications.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

This type of equity grant is a common practice in the biotechnology and healthcare industry to incentivize and retain key executives.

Comparison to Industry Standards

• Equity grants, including stock options and restricted stock units, are a standard component of executive compensation packages in the biotech industry.
• Companies like Illumina, Exact Sciences, and Myriad Genetics also use similar equity-based compensation to align executive interests with shareholder value.
• The vesting schedules described are typical for these types of grants, often spanning three to four years with a cliff vesting period followed by monthly or quarterly vesting.

Stakeholder Impact

• Shareholders may view this as a positive sign of incentivizing management.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, equity compensation, executive compensation, vesting, Guardant Health, insider trading, form 4